Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study.
Álvaro-Gracia JM, Sanchez-Piedra C, Culqui D, Rosello R, Garcia-Dorta A, Campos C, Manrique-Arija S, Ruiz-Montesinos D, Ros-Vilamajo I, Rodríguez-Lozano C, Freire-González M, Caliz R, Bohorquez C, Mateo Soria L, Busquets N, Castrejon I, Sánchez-Alonso F, González-Dávila E, Diaz-Gonzalez F. Álvaro-Gracia JM, et al. RMD Open. 2023 Mar;9(1):e002936. doi: 10.1136/rmdopen-2022-002936. RMD Open. 2023. PMID: 36927849 Free PMC article.
Sjögren SER: National registry of the Spanish Society of Rheumatology of patients with primary Sjögren syndrome: Objectives and methodology.
Fernández Castro M, Andreu JL, Sánchez-Piedra C, Martínez Taboada V, Olivé A, Rosas J, Sánchez-Alonso F; en representación del Grupo de trabajo en Enfermedades Autoinmunes Sistémicas de la Sociedad Española de Reumatología (EAS-SER) y de la Unidad de Investigación de la Sociedad Española de Reumatología (UI-SER). Fernández Castro M, et al. Reumatol Clin. 2016 Jul-Aug;12(4):184-9. doi: 10.1016/j.reuma.2015.09.002. Epub 2015 Nov 23. Reumatol Clin. 2016. PMID: 26617051 Free article. English, Spanish.
Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.
Rúa-Figueroa I, Fernández Castro M, Andreu JL, Sanchez-Piedra C, Martínez-Taboada V, Olivé A, López-Longo J, Rosas J, Galindo M, Calvo-Alén J, Fernández-Nebro A, Alonso F, Rodríguez-Lozano B, Alberto García Vadillo J, Menor R, Narváez FJ, Erausquin C, García-Aparicio Á, Tomero E, Manrique-Arija S, Horcada L, Uriarte E, Gil S, Blanco R, López-González R, Boteanu A, Freire M, Galisteo C, Rodríguez-Gómez M, Díez-Álvarez E, Pego-Reigosa JM; Sjogrenser and Relesser Researchers and EAS-SER Group. Rúa-Figueroa I, et al. Arthritis Care Res (Hoboken). 2017 Jan;69(1):38-45. doi: 10.1002/acr.23015. Epub 2016 Nov 21. Arthritis Care Res (Hoboken). 2017. PMID: 27564390 Free article.
Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER).
Torrente-Segarra V, Corominas H, Sánchez-Piedra C, Fernández-Castro M, Andreu JL, Martínez-Taboada VM, Olivé A, Rosas J, Sánchez-Alonso F; SJOGRENSER Study Group of the Spanish Society of Rheumatology. Torrente-Segarra V, et al. Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):28-34. Epub 2017 Feb 24. Clin Exp Rheumatol. 2017. PMID: 28240585
Objectives and methodology of BIOBADASER phase iii.
Sanchez-Piedra C, Hernández Miguel MV, Manero J, Roselló R, Sánchez-Costa JT, Rodríguez-Lozano C, Campos C, Cuende E, Fernández-Lopez JC, Bustabad S, Martín Domenech R, Pérez-Pampín E, Del Pino-Montes J, Millan-Arciniegas AM, Díaz-González F, Gómez-Reino JJ; en representación del Grupo de trabajo BIOBADASER Fase III. Sanchez-Piedra C, et al. Reumatol Clin (Engl Ed). 2019 Jul-Aug;15(4):229-236. doi: 10.1016/j.reuma.2017.08.001. Epub 2017 Sep 19. Reumatol Clin (Engl Ed). 2019. PMID: 28935290 Free article. English, Spanish.
Status of Rheumatology in Spain in 2017: 2.0 Rheumatologists per 100,000 Population.
Sanchez-Piedra C, Yoldi B, Valero M, Andreu JL, Díaz-González F, Gómez-Reino JJ; en representación del Grupo de trabajo BIOBADASER Fase III. Sanchez-Piedra C, et al. Reumatol Clin (Engl Ed). 2018 Sep-Oct;14(5):311-312. doi: 10.1016/j.reuma.2017.10.003. Epub 2017 Nov 11. Reumatol Clin (Engl Ed). 2018. PMID: 29132748 Free article. English, Spanish. No abstract available.
REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients.
González-Álvaro I, Blasco AJ, Lázaro P, Sánchez-Piedra C, Almodovar R, Bachiller-Corral J, Balsa A, Caliz R, Candelas G, Fernández-Carballido C, García-Aparicio A, García-Magallón B, García-Vicuña R, Gómez-Centeno A, Ortiz AM, Sanmartí R, Sanz J, Tejera B. González-Álvaro I, et al. Heliyon. 2017 Nov 14;3(11):e00452. doi: 10.1016/j.heliyon.2017.e00452. eCollection 2017 Nov. Heliyon. 2017. PMID: 29264411 Free PMC article.
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER.
Bethencourt Baute JJ, Sanchez-Piedra C, Ruiz-Montesinos D, Medrano San Ildefonso M, Rodriguez-Lozano C, Perez-Pampin E, Ortiz A, Manrique S, Roselló R, Hernandez V, Campos C, Sellas A, Sifuentes-Giraldo WA, García-González J, Sanchez-Alonso F, Díaz-González F, Gómez-Reino JJ, Bustabad Reyes S; BIOBADASER study group. Bethencourt Baute JJ, et al. Arthritis Res Ther. 2018 Oct 10;20(1):227. doi: 10.1186/s13075-018-1728-3. Arthritis Res Ther. 2018. PMID: 30305158 Free PMC article.
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry.
Hernandez MV, Sanchez-Piedra C, Garcia-Magallon B, Cuende E, Manero J, Campos-Fernandez C, Martin-Domenech R, Del Pino-Montes J, Manrique S, Castro-Villegas MC, Ruiz-Montesinos D, Sanchez-Alonso F, Diaz-Gonzalez F, Cea-Calvo L, Gómez-Reino JJ; BIOBADASER Study Group. Hernandez MV, et al. Rheumatol Int. 2019 Mar;39(3):509-515. doi: 10.1007/s00296-018-4177-z. Epub 2018 Oct 24. Rheumatol Int. 2019. PMID: 30353269 Free article.
84 results